Brief Article
Copyright ©2009 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Cardiol. Dec 31, 2009; 1(1): 46-50
Published online Dec 31, 2009. doi: 10.4330/wjc.v1.i1.46
Serum oxidizability potential of ischemic heart disease patients is associated with exercise test results and disease severity
Allah Shanati, Yelena Rivlin, Sergei Shnizer, Uri Rosenschein, Ehud Goldhammer
Allah Shanati, Yelena Rivlin, Sergei Shnizer, Uri Rosenschein, Ehud Goldhammer, Department of Cardiology and Cardiac Rehabilitation, Bnai Zion Medical Center, and the Faculty of Medicine, Technion, Haifa 31048, Israel
Author contributions: Shanati A provided database and performed the research; Rivlin Y performed exercise test procedures and provided database; Shnizer S performed laboratory procedures; Rosenschein U wrote the paper; Goldhammer E designed and performed this research, analyzed the data and wrote the paper.
Correspondence to: Ehud Goldhammer, Professor, MD, FESC, Department of Cardiology and Cardiac Rehabilitation, Bnai Zion Medical Center, and the Faculty of Medicine, Technion, 47, Golomb Str., Haifa 31048, Israel.
Telephone: +972-4-8359225 Fax: +972-4-8359702
Received: November 5, 2009
Revised: November 19, 2009
Accepted: November 23, 2009
Published online: December 31, 2009

AIM: To find out whether serum oxidizability potential correlates with exercise test (EXT) parameters and predicts their results in chronic ischemic heart disease (IHD) patients.

METHODS: Oxidizability potential was determined in a group of chronic IHD patients who underwent a symptom limited EXT upon initiation of a cardiac rehabilitation program. The thermo-chemiluminescence (TCL) assay was used to assess serum oxidizability potential. This assay is based on heat-induced oxidation of serum, leading to the formation of electronically excited species in the form of unstable carbonyls, which further decompose into stable carbonyls and light energy (low chemiluminescence). Measured photons emission is represented by a kinetic curve which is described by its amplitude and slope (= ratio). We assessed the correlations of TCL ratio with exercise duration, metabolic equivalents (METS), maximal heart rate (mHR), maximal systolic BP, > 1 mm S-T depression, diabetes, hypertension, smoking, left ventricular ejection fraction (LVEF) > or < 40%, previous myocardial infarction, and aorto-coronary by-pass surgery and compared to the TCL ratio measured in a group of healthy controls.

RESULTS: A high TCL ratio (%) correlated well with METS (r = 0.84), with mHR (r = 0.79) and with exercise induced S-T segment shift (r = 0.87, P < 0.05). A lower serum oxidizability potential, expressed as a low TCL ratio, thus suggestive of a previous high oxidative stress, was found in IHD patients compared to healthy controls, and, in particular, in patients with low LVEF%. The TCL ratio (%) in IHD patients was 193 ± 21, compared to 215 ± 13 in controls (P < 0.05), and was 188 ± 14.7 in patients with LVEF < 40% as compared to 200 ± 11.9 in those with LVEF > 40% (P < 0.01). A trend for lower TCL ratio (%) was found in diabetic, hypertensive, and post-coronary bypass surgery patients. A paradoxically low TCL ratio (low oxidizability potential) was observed in patients without S-T depression compared to patients with S-T depression (189 ± 22 vs 201 ± 15, P = NS), due to the fact these patients had a much lower LVEF% and a lower exercise capacity.

CONCLUSION: Serum oxidizability potential is associated with EXT parameters, results, and IHD severity. TCL ratio is an “easy-to-measure marker” that might be incorporated into risk assessment and prediction in chronic IHD patients.

Keywords: Oxidative stress, Exercise test, Ischemic heart disease